Educational Session - Effective blood pressure lowering reduces cardiovascular risk
Supported by an unrestricted grant from Bayer AG
Chairpersons: A. Coca (Barcelona, Spain) and A.J. Manolis (Athens, Greece)
Introduction
A.J. Manolis (Athens, Greece)
[WEBCAST] |
|
Extending the BP-lowering benefits of nifedipine GITS to patients with ISH H. Elliott (UK)
[WEBCAST] |
|
BP reduction and clinical outcomes – update from ONTARGET
R. Asmar (Paris, France)
[WEBCAST] |
|
Challenges in treating metabolic syndrome – the advantages of prescribing ARBs alone and in combination
A. de la Sierra (Barcelona, Spain)
[WEBCAST] |
|
Combining antihypertensive drugs classes – extending the evidence and maximising the benefits
P.A. Meredith (Glasgow, UK)
[WEBCAST] |
<< back
|